Evidence map›Paper›PMID 36456876›Full record

ArticleDigestive diseases and sciences2023

Dynamics of Serum Procalcitonin Can Predict Outcome in Patients of Infected Pancreatic Necrosis: A Prospective Analysis.

Jayanta Samanta, Jahnvi Dhar, Chhagan Lal Birda, Pankaj Gupta, Thakur Deen Yadav, Vikas Gupta, Saroj Kant Sinha, Rakesh Kochhar

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Acute pancreatitis: Translating early mechanisms to bedside management.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jayanta Samanta *Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. dj_samanta@yahoo.co.in.ORCID http://orcid.org/0000-0002-9277-5086
Jahnvi Dhar *Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Chhagan Lal BirdaDepartment of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pankaj GuptaDepartment of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Thakur Deen YadavDepartment of GI Surgery, Post Graduate Institute of Medical Education and Research, India, Chandigarh.
Vikas GuptaDepartment of GI Surgery, Post Graduate Institute of Medical Education and Research, India, Chandigarh.
Saroj Kant SinhaDepartment of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Rakesh KochharDepartment of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTimely intervention can alter outcome in patients of infected pancreatic necrosis (IPN) but lacks adequate biomarker. Role of serum procalcitonin (PCT) in the management of IPN is understudied, and hence, this study was planned. METHODOLOGY: All patients of acute pancreatitis with IPN without prior intervention were included. Baseline demographic, radiological and laboratory parameters were documented. PCT was measured at baseline, prior to intervention, and thereafter every 72 h. Patients were grouped into those having baseline PCT < 1.0 ng/mL and those with PCT ≥ 1.0 ng/mL and various outcome measures were compared.

resultsOf the 242 patients screened, 103 cases (66 males; 64.1%) with IPN were grouped into 2: PCT < 1.0 ng/mL (n = 29) and PCT ≥ 1.0 ng/mL (n = 74). Patients with baseline PCT ≥ 1.0 ng/mL had significantly more severe disease scores. 16 out of 19 patients with rise in PCT on day-7 post-intervention expired. PCT ≥ 1.0 ng/mL group had higher need for ICU (p = 0.001) and mortality (p = 0.044). PCT > 2.25 ng/mL (aOR 22.56; p = 0.013) at baseline and failure in reduction of PCT levels to < 60% of baseline at day-7 post-intervention (aOR 53.76; p = 0.001) were significant mortality predictors.

conclusionBaseline PCT > 1.0 ng/mL is associated with poor outcome. PCT > 2.25 ng/mL and failure in reduction of PCT levels to < 60% of its baseline at day-7 post-intervention can identify high-mortality risk patients.

Indexed as

Intraabdominal InfectionsPancreatitis, Acute NecrotizingAcute DiseaseBiomarkersCalcitoninCalcitonin Gene-Related PeptideHumansMaleProcalcitoninPrognosisProtein PrecursorsBiomarkersCalcitoninCalcitonin Gene-Related PeptideProcalcitoninProtein PrecursorsBiomarkersPancreatic necrosisPercutaneous catheter drainageRadiological intervention

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.